Since oxidative stress, inflammation, and impaired proteostasis are significantly involved in the pathogenesis of AD [7], the KEAP1-NRF2 system has emerged as a promising therapeutic target for the disease [8]. The gene discussed is NFE2L2; the disease is Alzheimer disease.